Interchange Capital Partners, LLC Invitae Corp Transaction History

Interchange Capital Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$0.42 - $0.72 $736 - $1,262	-1,753 Reduced 5.76%	28,706 $18,000
Q2 2023 Aug 08, 2023	BUY	$1.05 - $1.63 $12,829 - $19,916	12,219 Added 66.99%	30,459 $34,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $4,146 - $9,432	3,455 Added 23.37%	18,240 $24,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $15,181 - $32,049	-8,878 Reduced 37.52%	14,785 $27,000
Q3 2022 Nov 07, 2022	SELL	$1.9 - $8.63 $8,063 - $36,625	-4,244 Reduced 15.21%	23,663 $58,000
Q2 2022 Aug 05, 2022	SELL	$2.13 - $9.01 $2,010 - $8,505	-944 Reduced 3.27%	27,907 $68,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $53,204 - $132,078	8,472 Added 41.57%	28,851 $229,000
Q4 2021 Feb 04, 2022	BUY	$14.7 - $28.67 $299,571 - $584,265	20,379 New	20,379 $311,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $711,630 - $1.1 Million	-27,276 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$33.06 - $56.93 $129,132 - $222,368	3,906 Added 16.71%	27,276 $1.14 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $913,533 - $1.34 Million	23,370 New	23,370 $977,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Interchange Capital Partners, LLC with notifications on news.